1. Accelerate industrial intelligence upgrade and digital optimization plan
Since 2022, CTSP Bureau has promoted the 'Accelerated Industrial Intelligent Upgrade and Digital Optimization Plan', hoping to develop innovative solutions for software and hardware integration by condensing the R&D and innovation energy of Industry-University-Research, and assist the park manufacturers to strengthen the transformation and upgrading of intelligent and innovative technologies, upgrade the manufacturing technologies of key software and hardware equipment, modules and components, and promote the intelligent and high-value development of the industry. In 2022-2023, it planned to approve 8 cooperative development projects in Industry-University-Research and subsidize the park manufacturers by 31.048 million dollars.
The approved plan covers intelligent storage, intelligent processing system, automatic test process integration, AI thermal displacement modeling technology, blockchain application, intelligent screen washing production system, intelligent material dispatching and storage technology, intelligent machine vision identification, etc. Through the integration of technologies such as cloud application service and intelligent production line equipment, production efficiency, speed and flexibility will be implemented in flexible production, and through the development of related technologies, the application of multiple intelligent manufacturing technologies will be derived, and cross-domain application talents will be cultivated.
2. Cross-domain promotion plan of CTSP precision health industry
In order to promote R&D and innovation of precision health industry in central area, integrate ICT information and communication energy with Bio-biomedical industry, and introduce it into the field of medical care, since 2022, the bureau has promoted the Cross-domain Promotion Plan of CTSP precision health industry, taking precise disease prevention/prediction, precise diagnosis, precise treatment and care as the planned development field, promoted the cooperation between biomedical industry and medical institutions in central area, and promoted the technology transfer, product development or integration of relevant manufacturers for clinical verification and application of precision health products.
In 2022-2023, the subsidy scheme approved 11 medical cooperation cases and 1 marketing case in Industry-University-Research, providing about NT$ 38.16 million to help manufacturers invest in R&D, manufacturing and industrial marketing of products such as precise prevention, diagnosis, treatment and care.
